XING Han-ying, WANG Chao, ZHANG Hui-xin, et al. Tongxinluo Inhibits Expression of HIF-1a/VEGF/VEGFR-2 Expression in Retina Tissues of KK/Upj-Ay Mice[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(21): 97-101.
DOI:
XING Han-ying, WANG Chao, ZHANG Hui-xin, et al. Tongxinluo Inhibits Expression of HIF-1a/VEGF/VEGFR-2 Expression in Retina Tissues of KK/Upj-Ay Mice[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(21): 97-101. DOI: 10.13422/j.cnki.syfjx.2015210097.
Tongxinluo Inhibits Expression of HIF-1a/VEGF/VEGFR-2 Expression in Retina Tissues of KK/Upj-Ay Mice
Objective: To observe the effect of Tongxinluo on expression of hypoxia inducible factor 1a (HIF-1a)
vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor 2 (VEGFR2) in retina tissues of KK/Upj-Ay mice with spontaneous diabetes
and explore the protective mechanism of Tongxinluo on diabetic retinopathy. Method: Forty KK/Upj-Ay mice were randomly divided into 4 groups:model group (n=10)
Tongxinluo low-dose group (n=10
1 g·kg-1)
median-dose group (n=10
2 g·kg-1) and high-dose group (n=10
4 g·kg-1) group. The mice were given Tongxinluo intragastrically for 12 weeks. C57BL/6 mice were chosen as normal group (n=10). The whole blood viscosity and plasma viscosity were measured by blood viscometer and red blood cell aggregation index was measured by ektacytometer. The expression levels of VEGF and VEGFR-2 genes in retina tissues of mice were detected with real time fluorescence quantitative PCR method. Western-blot method was used to detect the expression levels of HIF-1a
VEGF
VEGFR2 in retina tissues. Result: Compared with C57BL/6 mice in the normal group
the whole blood viscosity
the plasma viscosity and the red blood cell aggregation index were all increased in model group (P<0.01). Compared with the model group
red blood cell aggregation index was significantly decreased in KK/Upj-Ay mice after treatment by middle dose and high dose Tongxinluo (P<0.05
P<0.01)
and the whole blood viscosity at low shear rate
and plasma viscosity were also significantly decreased in high-dose Tongxinluo group (P<0.01). HIF-1a/VEGF/VEGFR-2 proteins and VEGF/VEGFR-2 mRNA expressions in retina tissues of model group mice were significantly higher than those in normal group (P<0.01)
while after treatment with Tongxinluo
HIF-1a/VEGF/VEGFR-2 mRNA and protein expressions were significantly lower in low-dose
median-dose and high-dose groups than those in model group(P<0.01). Conclusion: Tongxinluo may inhibit HIF-1a/VEGF/VEGFR-2 signal pathways in retina tissues of diabetic mice
which may be related to it's improvement of hemorrheology.
Effect of Tongmai Tangyanming Capsule on Levels of Vascular EndothelialGrowth Factor in Patients with Non-proliferative Diabetic Retinopathy
Effect of Flavonoid from Leaf on Expressions of CTGF, VEGF,HIF-1 in Retina of KKAy Mice
Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway
Sequential Administration of Dihuang Baoyuan Granules and Fuling Yunhua Granules for Teating Type 2 Diabetes Mellitus in Mice
Protective Effect of Taohong Siwutang on Cerebral Ischemia-reperfusion Injury Based on A1/A2 Phenotype Transformation of Astrocytes Mediated by JAK2/STAT3 Pathway
Related Author
XU Han-song
KONG De-ming
XIANG Hui
DENG Zhen-de
HUANG Yong-zhi
PAN Li-sha
YAN Lu-ning
SHE Xiao
Related Institution
Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Hunan University of Chinese Medicine
Hunan University of Chinese Medicine
Hu Tianbao Community-Level Old Chinese Medicine Studio
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangdong Engineering Research Center of Commercialization of Medical Institution Preparations and Traditional Chinese Medicines, Guangdong Engineering Technology Research Center of Commercialization of Linnan Special Medical Institution Preparations